
Were you diagnosed with NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) after taking Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound?
NAION is a serious condition where reduced blood flow damages the optic nerve, leading to sudden vision loss, blind spots, or permanent changes in how you see.
If you have a confirmed NAION diagnosis, you may qualify for compensation.
Take our 30-second eligibility quiz to see if you qualify for significant compensation.

NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) happens when reduced blood flow damages the optic nerve, causing sudden blurred vision, blind spots, or long-term vision loss.
If you took Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound and haven’t confirmed your condition, speak with your doctor about a NAION diagnosis — as individuals with a confirmed diagnosis may qualify for significant compensation.
Compassionate Support: Providing emotional and legal support to help you navigate the challenges of recovery.
You may be eligible to file a claim if you were diagnosed with Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) after using a branded GLP-1 medication such as Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound.
There are no upfront fees. Your legal team only takes a percentage of any compensation you win; if you don’t receive a payout, you don’t pay anything.
Most submissions receive an initial review within 24–48 hours. Your legal team will contact you with next steps if you qualify.
Yes. All information you submit is secure, encrypted, and shared only with qualified attorneys reviewing your potential claim.
